Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
11 October 2013
Header
Header image
Highlight of the week

Highlight of the week

Access to Medicines: what should the industry contribute? (part 2) - Final report available
10 October 2013

Access to Medicines: what should the industry contribute? (Part II: Supply Chain & Delivery Systems - The Last Mile Challenge) - The final report as well as the debate photos and presentations are now available on our website

 

 

Read more

Highlight of the week

New Twitter Account on Anti-Counterfeiting
10 October 2013

@EU_ESM - New Twitter Account. Do follow and stay tuned for updates, articles and events about anti-counterfeiting and fake medicines. The European Stakeholder Model : A Medicines Verification System for Europe - ensuring patients have access to safe medicines. 

Read more

From our blog

From our blog

Pharma and Social Media
09 October 2013 by Communication Team

With 1.11 billion (March 2013) Facebook users versus 400 million (December 2012) Google+ users, rapidly growing social media websites can be scary. Social media platforms [...] Read more

From our blog

European Cancer Congress 2013 - Oncology and Innovation
07 October 2013 by Richard Bergström

Earlier this month, I had the opportunity to take part in the European Cancer Congress, which brings together leaders in oncology from across Europe to [...] Read more

Videos

Video

Ensuring Quality Affordable Medicines in Developing Countries: Accra, Ghana June 2013

A snapshot video of the multi-stakeholder dialogue on affordability and quality of medicines in developing countries hosted by the Access to Medicine Foundation in Accra, Ghana on 25-26 June, 2013. For a full report, please check our website.

View video

What we are reading

What we are reading

Malaria vaccine: Hopes rise for 2015 target after successful trials
10 October 2013

This week's news on a potential malaria vaccine could have great implications for global health. A vaccine in clinical trials was shown to nearly halve cases of the often-deadly illness in children ages five to seven months. This Guardian article explains further on how the vaccine, if successful, could save millions in the worst-hit countries.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail